The intravenous infusion pumps market size has grown strongly in recent years. It will grow from $6.37 billion in 2025 to $6.98 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to expansion of hospital infrastructure, rising use of intravenous drug delivery, increasing prevalence of chronic diseases, adoption of programmable infusion systems, improvements in pump accuracy and reliability.
The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $9.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for interoperable infusion devices, rising focus on patient-centric care models, expansion of remote patient monitoring, growing investments in smart healthcare infrastructure, increasing adoption of home-based infusion therapies. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising use of dose error reduction software, growing integration of connected hospital systems, expansion of ambulatory and home infusion therapies, enhanced focus on medication safety.
The growing prevalence of bleeding disorders is expected to drive the growth of the intravenous infusion pump market. Bleeding disorders refer to a group of medical conditions that impair the body's ability to form blood clots correctly. The rise in these disorders is largely due to genetic factors and the increasing number of consanguineous marriages, which heighten the chances of inherited clotting deficiencies in populations. Intravenous infusion pumps play a crucial role in the treatment of bleeding disorders, as they are used to deliver clotting factor replacement therapies in a precise and controlled manner, ensuring patients receive the correct dose at the right time. For example, in April 2025, Pfizer, a US-based biopharmaceutical company, reported that over 11,800 people in the United Kingdom were living with haemophilia A or B in 2023-2024, while the condition affects more than 800,000 people worldwide and is typically diagnosed in early childhood. As a result, the increasing prevalence of bleeding disorders is contributing to the growth of the intravenous infusion pump market.
Major companies in the intravenous infusion pumps market are focusing on technological innovations, such as real-time flow monitoring systems, to detect and correct deviations in infusion rates dynamically, enhancing accuracy and patient safety. Real-time flow monitoring systems are advanced medical devices that continuously measure and track the flow rate of fluids, such as medication or blood, to ensure accurate and timely delivery during treatment. For example, in February 2023, Mindray, a China-based manufacturer of high-tech medical devices, launched its BeneFusion I-/U Series infusion systems. These systems feature Smart Accurate™ technology, which continuously monitors the actual drug flow rate and provides real-time feedback to correct any deviations. The pumps also offer sleek, intuitive user interfaces with full-touch screens, a customizable drug library, and a patented BolusGUARD motorized syringe loading system to prevent unintentional boluses during loading. Additionally, they support connectivity through Mindray’s M-IoT system for centralized device management, maintenance analytics, and drug library updates, enhancing safety and efficiency across hospital networks.
In May 2025, Boston Scientific, a US-based medical device company, acquired Intera Oncology, Inc. for approximately $172 million. This acquisition aims to enhance Boston Scientific's interventional oncology portfolio by integrating Intera Oncology’s constant-flow Intera 3000 Hepatic Artery Infusion Pump and floxuridine chemotherapy drug. The system is used to deliver targeted hepatic artery infusion (HAI) therapy for liver tumors. Intera Oncology, Inc., a US-based company, specializes in implantable infusion pumps and chemotherapy drug delivery systems, with a strong focus on hepatic artery infusion therapy.
Major companies operating in the intravenous infusion pumps market are B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation.
North America was the largest region in the intravenous infusion pumps market in 2025. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intravenous infusion pumps market by increasing costs of imported electronic components, sensors, software modules, plastics, and precision manufacturing equipment used in pump systems and disposables. Healthcare providers and manufacturers in North America and Europe are most affected due to global sourcing dependencies, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing acquisition costs and influencing hospital procurement decisions. However, they are also driving domestic production, localized assembly of infusion devices, and innovation in cost-efficient and modular pump designs.
The intravenous infusion pumps market research report is one of a series of new reports that provides intravenous infusion pumps market statistics, including intravenous infusion pumps industry global market size, regional shares, competitors with a intravenous infusion pumps market share, detailed intravenous infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous infusion pumps industry. This intravenous infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
In the realm of medical devices, intravenous infusion pumps are vital tools designed for the precise administration of medications into patients' bodies.
The intravenous infusion pumps market, as discussed in this report, is categorized into several product segments, including volumetric, syringe, enteral, ambulatory, IV disposables, and others. The syringe type is characterized by a reciprocating mechanism for drug delivery and is driven by a plunger. The market is further divided based on application, encompassing chemotherapy, diabetes treatment, gastroenterology, analgesia and pain management, pediatrics and neonatology care, haematology, and other medical uses. Additionally, the market is segmented by end-users, such as hospitals, ambulatory surgical centers, cancer treatment centers, specialty clinics, and other healthcare facilities.
The intravenous infusion pumps market consists of sales of volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $9.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for interoperable infusion devices, rising focus on patient-centric care models, expansion of remote patient monitoring, growing investments in smart healthcare infrastructure, increasing adoption of home-based infusion therapies. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising use of dose error reduction software, growing integration of connected hospital systems, expansion of ambulatory and home infusion therapies, enhanced focus on medication safety.
The growing prevalence of bleeding disorders is expected to drive the growth of the intravenous infusion pump market. Bleeding disorders refer to a group of medical conditions that impair the body's ability to form blood clots correctly. The rise in these disorders is largely due to genetic factors and the increasing number of consanguineous marriages, which heighten the chances of inherited clotting deficiencies in populations. Intravenous infusion pumps play a crucial role in the treatment of bleeding disorders, as they are used to deliver clotting factor replacement therapies in a precise and controlled manner, ensuring patients receive the correct dose at the right time. For example, in April 2025, Pfizer, a US-based biopharmaceutical company, reported that over 11,800 people in the United Kingdom were living with haemophilia A or B in 2023-2024, while the condition affects more than 800,000 people worldwide and is typically diagnosed in early childhood. As a result, the increasing prevalence of bleeding disorders is contributing to the growth of the intravenous infusion pump market.
Major companies in the intravenous infusion pumps market are focusing on technological innovations, such as real-time flow monitoring systems, to detect and correct deviations in infusion rates dynamically, enhancing accuracy and patient safety. Real-time flow monitoring systems are advanced medical devices that continuously measure and track the flow rate of fluids, such as medication or blood, to ensure accurate and timely delivery during treatment. For example, in February 2023, Mindray, a China-based manufacturer of high-tech medical devices, launched its BeneFusion I-/U Series infusion systems. These systems feature Smart Accurate™ technology, which continuously monitors the actual drug flow rate and provides real-time feedback to correct any deviations. The pumps also offer sleek, intuitive user interfaces with full-touch screens, a customizable drug library, and a patented BolusGUARD motorized syringe loading system to prevent unintentional boluses during loading. Additionally, they support connectivity through Mindray’s M-IoT system for centralized device management, maintenance analytics, and drug library updates, enhancing safety and efficiency across hospital networks.
In May 2025, Boston Scientific, a US-based medical device company, acquired Intera Oncology, Inc. for approximately $172 million. This acquisition aims to enhance Boston Scientific's interventional oncology portfolio by integrating Intera Oncology’s constant-flow Intera 3000 Hepatic Artery Infusion Pump and floxuridine chemotherapy drug. The system is used to deliver targeted hepatic artery infusion (HAI) therapy for liver tumors. Intera Oncology, Inc., a US-based company, specializes in implantable infusion pumps and chemotherapy drug delivery systems, with a strong focus on hepatic artery infusion therapy.
Major companies operating in the intravenous infusion pumps market are B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation.
North America was the largest region in the intravenous infusion pumps market in 2025. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intravenous infusion pumps market by increasing costs of imported electronic components, sensors, software modules, plastics, and precision manufacturing equipment used in pump systems and disposables. Healthcare providers and manufacturers in North America and Europe are most affected due to global sourcing dependencies, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing acquisition costs and influencing hospital procurement decisions. However, they are also driving domestic production, localized assembly of infusion devices, and innovation in cost-efficient and modular pump designs.
The intravenous infusion pumps market research report is one of a series of new reports that provides intravenous infusion pumps market statistics, including intravenous infusion pumps industry global market size, regional shares, competitors with a intravenous infusion pumps market share, detailed intravenous infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous infusion pumps industry. This intravenous infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
In the realm of medical devices, intravenous infusion pumps are vital tools designed for the precise administration of medications into patients' bodies.
The intravenous infusion pumps market, as discussed in this report, is categorized into several product segments, including volumetric, syringe, enteral, ambulatory, IV disposables, and others. The syringe type is characterized by a reciprocating mechanism for drug delivery and is driven by a plunger. The market is further divided based on application, encompassing chemotherapy, diabetes treatment, gastroenterology, analgesia and pain management, pediatrics and neonatology care, haematology, and other medical uses. Additionally, the market is segmented by end-users, such as hospitals, ambulatory surgical centers, cancer treatment centers, specialty clinics, and other healthcare facilities.
The intravenous infusion pumps market consists of sales of volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intravenous Infusion Pumps Market Characteristics
3. Intravenous Infusion Pumps Market Supply Chain Analysis
4. Global Intravenous Infusion Pumps Market Trends and Strategies
5. Intravenous Infusion Pumps Market Analysis of End Use Industries
7. Global Intravenous Infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intravenous Infusion Pumps Total Addressable Market (TAM) Analysis for the Market
9. Intravenous Infusion Pumps Market Segmentation
10. Intravenous Infusion Pumps Market Regional and Country Analysis
11. Asia-Pacific Intravenous Infusion Pumps Market
12. China Intravenous Infusion Pumps Market
13. India Intravenous Infusion Pumps Market
14. Japan Intravenous Infusion Pumps Market
15. Australia Intravenous Infusion Pumps Market
16. Indonesia Intravenous Infusion Pumps Market
17. South Korea Intravenous Infusion Pumps Market
18. Taiwan Intravenous Infusion Pumps Market
19. South East Asia Intravenous Infusion Pumps Market
20. Western Europe Intravenous Infusion Pumps Market
21. UK Intravenous Infusion Pumps Market
22. Germany Intravenous Infusion Pumps Market
23. France Intravenous Infusion Pumps Market
24. Italy Intravenous Infusion Pumps Market
25. Spain Intravenous Infusion Pumps Market
26. Eastern Europe Intravenous Infusion Pumps Market
27. Russia Intravenous Infusion Pumps Market
28. North America Intravenous Infusion Pumps Market
29. USA Intravenous Infusion Pumps Market
30. Canada Intravenous Infusion Pumps Market
31. South America Intravenous Infusion Pumps Market
32. Brazil Intravenous Infusion Pumps Market
33. Middle East Intravenous Infusion Pumps Market
34. Africa Intravenous Infusion Pumps Market
36. Intravenous Infusion Pumps Market Competitive Landscape and Company Profiles
37. Intravenous Infusion Pumps Market Other Major and Innovative Companies
40. Intravenous Infusion Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intravenous Infusion Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intravenous infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intravenous infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Volumetric; Syringe; Enteral; Ambulatory; IV Disposables; Other Products2) By Application: Chemotherapy; Diabetes; Gastroenterology; Analgesia/Pain Management; Pediatrics/Neonatology; Hematology; Other Applications
3) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Treatment Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Volumetric: Large-volume Pumps; Small-volume Pumps2) By Syringe: Micro Syringe Pumps; Macro Syringe Pumps
3) By Enteral: Portable Enteral Pumps; Stationary Enteral Pumps
4) By Ambulatory: Patient-controlled Analgesia (PCA) Pumps; Insulin Pumps; Disposable Pumps
5) By IV Disposables: IV Tubing Sets; IV Catheters; IV Cannulas; IV Solutions
6) By Other Products: Implantable Pumps; Smart Pumps; Elastomeric Pumps
Companies Mentioned: B. Braun Melsungen AG; Baxter International Inc.; Medtronic plc; Fresenius Kabi AG; Smiths Medical Inc.; Becton Dickinson and Company (BD); Terumo Corporation; F. Hoffmann-La Roche Ltd.; ICU Medical Inc.; IRadimed Corporation; Mindray Medical International Limited; Zyno Medical LLC; Tandem Diabetes Care Inc.; Johnson & Johnson; Micrel Medical Devices SA; Q-Core Medical Ltd.; Moog Inc.; Roche Diagnostics International AG; Nipro Corporation; Animas Corporation; Ypsomed Holding AG; Valeritas Inc.; ZOLL Medical Corporation; Codan Medical A/S; Halyard Health Inc.; InfuSystem Holdings Inc.; Hospira Infusion Systems; CareFusion Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intravenous Infusion Pumps market report include:- B. Braun Melsungen AG
- Baxter International Inc.
- Medtronic plc
- Fresenius Kabi AG
- Smiths Medical Inc.
- Becton Dickinson and Company (BD)
- Terumo Corporation
- F. Hoffmann-La Roche Ltd.
- ICU Medical Inc.
- IRadimed Corporation
- Mindray Medical International Limited
- Zyno Medical LLC
- Tandem Diabetes Care Inc.
- Johnson & Johnson
- Micrel Medical Devices SA
- Q-Core Medical Ltd.
- Moog Inc.
- Roche Diagnostics International AG
- Nipro Corporation
- Animas Corporation
- Ypsomed Holding AG
- Valeritas Inc.
- ZOLL Medical Corporation
- Codan Medical A/S
- Halyard Health Inc.
- InfuSystem Holdings Inc.
- Hospira Infusion Systems
- CareFusion Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.98 Billion |
| Forecasted Market Value ( USD | $ 9.98 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
